Selected sources for competitive intelligence in biopharma
Jinfo Blog
12th June 2012
Abstract
Demand for different type of information (scientific, clinical, patent, business) can vary in deferent stages of drug development process (discovery, development, marketing). Published information can be collected using variety of online resources.
Item
Competitive Intelligence (CI) can be described as a process of gathering, analysing and interpreting internal and external intelligence on competitors and the competitive environment to guide a company’s strategy. Published information collection and analysis are the essential parts of CI and important in building understanding of the competitive environment and make assumptions for the future. Demand for different type of information (scientific, clinical, patent, business) can vary in deferent stages of drug development process (discovery, development, marketing). Published information can be collected using variety of online resources.
Scientific (biomedical) information is essential for early drug development process andusually comes from journals, books, conference proceedings, databases and other sources, such as PhD theses and scientific reports from professional societies and associations. This type of information can be accessed online from journals, databases such as PubMed and relevant scientific or medical conference websites.
Journal, database and conference aggregator sites also exist and these can help reduce workload, by searching across multiple journals, databases or conferences Some examples of aggregators are:
- Science Direct (journals)
- Dialog (databases)
- Medical Intelligence Solutions (conferences)
Clinical and Regulatory information essential for the development stage, when drug is going through clinical trials and country specific regulatory submission. This type of information can be accessed both free and via subscription. There are a number of free websites containing clinical trials information, the best known example probably being ClinicalTrials.gov. There is only one aggregator dedicated to clinical trials information – Informa's TrialTrove database . Drug databases, such as ADIS also contains clinical trials information.
Regulatory information can be accessed via the FDA website (for the US), EMA (EU), or country specific websites – all of which are usually free. Detailed regulatory information can be accessed through Thomson Reuters' IDRAC database.
Patent and intellectual property information, should be regular monitored to ensure that the company intellectual property (IP) is protected and other company IP is not infringed. This type of information can be found on a number of specific patent databases such as Micropatent, information aggregators including Dialog, or country specific websites such as the UK Patent Office. Whilst governmental and regulatory body sites are generally free, commercial databases often require a fee or subscription. As you evaluate the many sources of information for biopharma CI, it is essential to ensure quality and also consider the features some premium services offer, though there are many valuable sources available freely online as well.
Clinical and Regulatory information can be accessed both free and via subscription. There are a number of free websites containing clinical trials information, the best known example probably being ClinicalTrials.gov. There is only one aggregator dedicated to clinical trials information – Informa's TrialTrove database).
Regulatory information can be accessed via the FDA website (for the US), EMA (EU), or country specific websites – all of which are usually free. Detailed regulatory information can be accessed through Thomson Reuters' IDRAC database (http://www.idrac.com/FrontPage.aspx).
Business and market information can of course be found in an almost infinite number of sites on the web: news sites (eg. FierceBiotech), trade associations such as the ABPI, company websites, drug-specific sites, etc. However, for regulatory reasons, some of the resources are accessible only to healthcare professionals and may require registration.
There are also many business / market information providers that provide databases. These include news databases such as Factiva, drug databases (eg. Pipeline), company (Hoovers), analyst reports (PharmaTell), market reports (Datamonitor) and forecasts (EvaluatePharma), etc. Using aggregators of different databases such as Dialog it Is possible to search across several databases.
- Blog post title: Selected sources for competitive intelligence in biopharma
- Link to this page
- View printable version
- Essential resources for competitive intelligence research in biopharma
Tuesday, 12th June 2012
- Selected Sources for Pharmaceuticals
Monday, 20th September 2010 - Pharmaceutical industry: a discovery-led approach to social media [ABSTRACT]
Tuesday, 5th January 2010 - If They Only Knew: Finding Competitive Intelligence from the Websites of Your Competitors and Their Friends [ABSTRACT]
Wednesday, 29th October 2008
- Market landscape - Informa Group's Business Intelligence division
Tuesday, 25th July 2017
Community session
11th December 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024
How are information managers getting involved with AI? Navigating privacy, ethics, and intellectual property
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 23rd January 2025
- Clinic on contracting for AI (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024